ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Clinical trials for ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS explained in plain language.

Never miss a new study

Get alerted when new ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS trials appear

Sign up with your email to follow new studies for ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New shot offers hope for teens battling severe, itchy skin

Disease control Not yet recruiting

This study is testing an investigational injection called SHR-1819 to see if it can safely reduce the severe skin rash and intense itching of eczema in teenagers. About 200 teens, aged 12-17, whose eczema hasn't improved enough with standard creams will receive either the real in…

Matched conditions: ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Phase: PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Get alerted when new ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS trials appear

New shot offers hope for teens battling severe, itchy skin